Article: LUNESTA(R) Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry.(Clinical report)

Article: LUNESTA Study of Patients with Insomnia and Co-Morbid ...
Health & Medicine Week;  May 26, 2008 ;     700+ words ... ... publication of a study of LUNESTA tablets in patients ... anxiety disorder (GAD) in the May issue ... and co-existing GAD. The study also ... administration of LUNESTA to increase the magnitude ... insomnia and co-morbid GAD who took LUNESTA and escitalopram ...

Article: LUNESTA(R) Study of Patients with Insomnia and Co-Morbid ...
M2 Presswire;  May 13, 2008 ;     700+ words ... ... publication of a study of LUNESTA tablets in patients ... anxiety disorder (GAD) in the May issue ... and co-existing GAD. The study also ... administration of LUNESTA to increase the magnitude ... insomnia and co-morbid GAD who took LUNESTA and escitalopram ...

Article: Data Show Sepracor's Lunesta(R) Improved Insomnia in ...
Business Wire;  December 5, 2006 ;     700+ words ... ... efficacy and safety of LUNESTA([R]) brand eszopiclone ... Generalized Anxiety Disorder (GAD). The results will be ... for both insomnia and GAD were randomized to receive ... approved for the treatment of GAD, and either LUNESTA 3 mg (n=294) or placebo ...

Article: Lunesta misses Ph II efficacy endpoints.
Pharma Marketletter;  March 16, 2009 ;     500 words ...US drugmaker Sepracor's Lunesta (eszopiclone) failed to demonstrate efficacy in a mid-stage trial ... its primary efficacy endpoint, which was reduction in symptoms of GAD, as assessed using the clinician-rated Hamilton Anxiety Rating ...

Article: LUNESTA(TM) Brand Eszopiclone, Formerly ESTORRA, Approved ...
PR Newswire;  December 16, 2004 ;     700+ words ... ... approved the New Drug Application (NDA) for LUNESTA(TM) brand eszopiclone, formerly referred ... for the FDA's decision to not limit LUNESTA's indication to short-term use. Sepracor ... study with no evidence of tolerance." LUNESTA is indicated for the treatment of patients ...

Article: LUNESTA(TM) Now Widely Available by Prescription to Treat ...
PR Newswire;  April 7, 2005 ;     700+ words ... ... Sepracor Inc. today announced that LUNESTA(TM) (eszopiclone 1 mg, 2 mg and 3 ... prescription in most pharmacies nationwide. LUNESTA is the first and only sleep aid (prescription ... for long-term treatment of insomnia. LUNESTA is the first treatment in its class that ...

Article: LUNESTA(TM) Perimenopause-Menopause Study Data to Be ...
Business Wire;  September 30, 2005 ;     700+ words ... ... study evaluating safety and efficacy of LUNESTA(TM) brand eszopiclone for treatment ... placebo-controlled study, nightly use of LUNESTA 3 mg resulted in statistically significant ... treatment period. Patients treated with LUNESTA also demonstrated significant improvements ...